Pharmstandard International - Unicorn Nest

Pharmstandard International

Pharmstandard International

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

About

This fund was the most active in 2017. The fund usually participates in less than 2 investment rounds per year. Deals in the range of 5 - 10 millions dollars are most common for this fund.

OncoTartis is amongst the various portfolio company of this fund. Among their most successful investment fields, we have identified Biometrics, Biotechnology. Also, because of its portfolio diversification tendency, we can highlight 1 more industry for this fund. Also, a start-up has to be aged 6-10 years to expect investment from this fund.

The usual method for the fund is to invest in rounds with 2 other investors. The fund often co-invests with Millhouse LLC.

Fund Activity

Not operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together

Millhouse LLC

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: